Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
250.00    5.00 (2.04%)
Bid:
250.00
Ask:
251.00
Spread: 1.00 (0.40%)
Market Cap: £145.84m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Director/PDMR Shareholding

29 Sep 2016 11:59

RNS Number : 2218L
MJ Gleeson PLC
29 September 2016
Β 

29 September 2016

Β 

MJ Gleeson Plc

("the Company")

Β 

Notification of Transaction by Director

Β 

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company announces that it was notified on 28 September 2016 that North Atlantic Smaller Companies Investment Trust PLC, part of Harwood Capital LLP, to which Christopher Mills, Director of the Company is a beneficiary, sold 1,000,000 ordinary shares at an average price of 600 pence per Ordinary Share. As a consequence of this transaction Mr. Mills' is directly and indirectly interested, including those held by Related Persons, in 10,055,000 shares:

Β 

Β 

Shareholder

Β 

Shares Sold

Β 

Total held now

Percentage of Issued Share Capital

North Atlantic Smaller Companies Investment Trust plc

1,000,000

8,000,000

14.78%

Oryx International Growth Fund Ltd

0

2,000,000

3.70%

Roy Nominees

0

55,000

0.10%

Total

10,055,000

18.58%

Β 

Β 

Following the above disposal, his current shareholding, including those held by Related Persons, is as follows:

Β 

1.

Details of PDMR / person closely associated with them ('CAP')

a)

Name

Christopher Mills

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the

financial instrument

Ordinary Shares of Β£0.02 each

b)

Nature of the transaction

Disposal via indirect holding through North Atlantic Smaller Companies Investment Trust PLC, part of Harwood Capital LLP.

c)

Β 

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

600 pence per share

1,000,000 shares

Β 

Β 

Β 

Β 

Note: this was a single transaction.

d)

Aggregated information

Aggregated volume

Price

Not applicable - single transaction.

Β 

e)

Date of the transaction

Β 

28 September 2016

Β 

f)

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Β 

Enquiries:

Β 

S Allanson

Chief Financial Officer

MJ Gleeson plc Tel: 01142 612900

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHLLMMTMBATBRF
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.